EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fundus Autofluorescence in Diabetic Retinopathy

Otilia-Maria Dumitrescu, Mihail Zemba, Daniel Constantin Brănișteanu iD, Ruxandra Angela Pîrvulescu iD, Madalina Radu, Horia Tudor Stanca iD

Journal of Personalized Medicine · 26.07.2024 · 14 (8) · 793

DOI: 10.3390/jpm14080793 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 26.07.2024. Verfasst von Otilia-Maria Dumitrescu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy is a leading cause of visual morbidity worldwide. Fundus autofluorescence is a rapid, non-invasive imaging modality that has gained increased popularity in recent years in the multimodal evaluation of diabetic retinopathy and, in particular, of diabetic macular oedema. Acquired using either a fundus camera or the confocal scanning laser ophthalmoscope, short-wavelength and near-infrared autofluorescence are the most used techniques in diabetic retinopathy. In diabetic macular oedema, short-wavelength autofluorescence, in its cystoid pattern, is useful for detecting cystoid macular oedema. Increased spot hyperautofluorescence in short-wavelength and granular changes in near-infrared autofluorescence correlate well with other imaging findings, indicating photoreceptor and retinal pigment epithelium damage and being associated with decreased visual acuity. While also being a marker of oxidative stress, increased short-wavelength autofluorescence in the setting of diabetic macular oedema appears to be a prognostic factor for poor visual outcome, even after the resolution of the intraretinal fluid. Autofluorescence also helps in the assessment of diabetic retinal pigment epitheliopathy and choroidopathy. Fundus autofluorescence is an evolving technology that will assist in gaining further insight into the pathophysiology of diabetic retinopathy and allow for a more comprehensive evaluation of these patients.

Schlagwörter

Stichwörter der Autor:innen

diabetic macular oedemadiabetic retinopathyfundus autofluorescence

Autor:innen und Institutionen

  • Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
  • Department of Ophthalmology, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
  • Department of Ophthalmology, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.

ORCID-Profile: Daniel Constantin Brănișteanu, Ruxandra Angela Pîrvulescu, Horia Tudor Stanca

Zitieren

APA

Dumitrescu, O. M., Zemba, M., Brănișteanu, D. C., Pîrvulescu, R. A., Radu, M., & Stanca, H. T. (2024). Fundus Autofluorescence in Diabetic Retinopathy. Journal of Personalized Medicine, 14(8), 793. https://doi.org/10.3390/jpm14080793

Vancouver

Dumitrescu OM, Zemba M, Brănișteanu DC, Pîrvulescu RA, Radu M, Stanca HT. Fundus Autofluorescence in Diabetic Retinopathy. Journal of Personalized Medicine. 2024;14(8):793. doi:10.3390/jpm14080793

BibTeX
@article{Dumitrescu2024,
  author = {Dumitrescu, Otilia-Maria and Zemba, Mihail and Brănișteanu, Daniel Constantin and Pîrvulescu, Ruxandra Angela and Radu, Madalina and Stanca, Horia Tudor},
  title = {Fundus Autofluorescence in Diabetic Retinopathy},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {793},
  doi = {10.3390/jpm14080793}
}
Kostenlos starten →